Amphastar Pharmaceuticals AMPH Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's other income, net (note 6)?
- Amphastar Pharmaceuticals (AMPH) reported other income, net (note 6) of $575K in Q1 2026.
- How has Amphastar Pharmaceuticals's other income, net (note 6) changed year-over-year?
- Amphastar Pharmaceuticals's other income, net (note 6) increased by 125.7% year-over-year, from -$2.23M to $575K.
- What is the long-term trend for Amphastar Pharmaceuticals's other income, net (note 6)?
- Over 4 years (2021 to 2025), Amphastar Pharmaceuticals's other income, net (note 6) has grown at a -80.1% compound annual growth rate (CAGR), from $14.54M to $23K.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.